Inactive Instrument

Other languages Bio Gate AG Xetra

Equities

DE000BGAG981

End-of-day quote Xetra Other stock markets
- ^EUR	-

01/05	Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2023	01/05
Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29
Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants	31/23/31
Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants	31/23/31
Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29
Bio-Gate AG Auditor Raises 'Going Concern' Doubt	29/23/29
DD: Bio-Gate AG : Notification and public disclosure of transactions by persons	05/22/05
DD: Bio-Gate AG : Notification and public disclosure of transactions by persons	05/22/05
Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2022	06/22/06
Avicanna Completes its First Commercial Export of its Derma-Cosmetics Brand Pura H&W into the European Union	08/22/08
Avicanna Inc. Completes Its First Commercial Export of Its Derma-Cosmetics Brand Pura H&WÃ– into the European Union	07/22/07
Bio Gate : concludes another cooperation agreement with leading multinational implant manufacturer	05/22/05
Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2021	07/22/07
Bio-Gate AG Auditor Raises 'Going Concern' Doubt	07/22/07
Avicanna Expands its Derma-Cosmetics Brand Pura H&W into the European Union through a Partnership with Bio-Gate AG	05/22/05
Bio-Gate Ag Reports Earnings Results for the Half Year Ended June 30, 2021	06/21/06
Bio Gate : and Avicanna complete first phase of development on Cannabidiol and Micro Silver BG™ based skin care products for global commercialization	29/21/29
Bio-Gate AG announced that it expects to receive €2.505126 million in funding	21/21/21
Bio-Gate AG Successfully Markets Antiviral and Antibacterial Protective Film Spray for Surfaces	28/20/28
Bio-Gate AG announced that it expects to receive €0.500031 million in funding	12/20/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bio Gate AG Xetra

Equities

DE000BGAG981

Other languages

Filters